In-vitro activity of RP 59500, a new semisynthetic injectable pristinamycin against staphylococci

C von Eiff1, G Peters

  • 1Institute of Medical Microbiology, Westfälische Wilhelms-Universität Münster, Germany.

Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology
|April 1, 1996
PubMed

Insights

RP 59500, a novel streptogramin antibiotic, demonstrates potent in vitro antistaphylococcal activity comparable to vancomycin. It effectively inhibits both methicillin-susceptible and resistant strains of Staphylococcus aureus and coagulase-negative staphylococci.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Staphylococcal infections pose a significant threat, with increasing resistance to existing antibiotics.
  • Methicillin-resistant Staphylococcus aureus (MRSA) presents a particular challenge in clinical settings.
  • Novel antimicrobial agents are crucial for combating resistant bacterial strains.

Purpose of the Study:

  • To evaluate the in vitro efficacy of RP 59500, a new streptogramin, against staphylococci.
  • To compare the activity of RP 59500 with vancomycin and ciprofloxacin.
  • To assess the impact of methicillin resistance on the activity of these agents.

Main Methods:

  • Agar dilution method was employed for antimicrobial susceptibility testing.
  • A panel of 130 Staphylococcus aureus and 117 coagulase-negative staphylococci strains were tested.
  • Minimum inhibitory concentrations (MICs) were determined for RP 59500, vancomycin, and ciprofloxacin.

Main Results:

  • RP 59500 exhibited potent antistaphylococcal activity, with MICs ≤ 2 µg/mL for all tested strains.
  • The activity of RP 59500 was comparable to vancomycin against both S. aureus and coagulase-negative staphylococci.
  • RP 59500 and vancomycin maintained their efficacy regardless of methicillin resistance phenotype, unlike ciprofloxacin.

Conclusions:

  • RP 59500 is a promising new streptogramin with broad-spectrum activity against staphylococci, including resistant strains.
  • Its efficacy is not compromised by methicillin resistance, positioning it as a potential alternative to vancomycin.
  • Further clinical investigation of RP 59500 is warranted for treating staphylococcal infections.

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...